Trial intelligence / Profile preview

Levitra in PDE5 inhibitor-naive men with erectile dysfunction

NCT00668096Phase 4Completed

Sponsor
Bayer
Start
May 2004
Primary completion
Jan 2005
Modality
Small Molecules
Countries
7
01

Overview

Phase 4, randomised, double-blind trial in erectile dysfunction (ED) comparing Levitra with Placebo (2 arms). Primary endpoints: Global Assessment Question at 16 weeks, Sexual Encounter Profile 3 at 16 weeks and 1 more. Started May 2004; status: completed.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00668096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00668096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call